Bobbi Buell's Newsletter

Roberta L. Buell is a Principal at onPoint Oncology Inc., specializing in oncology reimbursement. With over 23 years of experience in billing, coding, and drug therapy reimbursement, she's a nationally recognized expert and frequent speaker on regulatory and reimbursement issues. Bobbi has led more than 600 seminars since 1991 and currently serves as content director for focalPoint® and assistPoint®. Learn more about Bobbi here .

December 2025

ACCESS Demo: The Future?

For my entire career (and that's a really long stretch), insurers, the government, and medical groups have been trying to figure out how to pay for better outcomes. The problem is that no one really knows how to define 'better'. Here we go again. The Centers for Medicare & Medicaid Services (“CMS”), through the CMS Innovation Center (“CMMI”), has announced the ACCESS Model—Advancing Clinical Care, Equity and System Sustainability , a demonstration model that aims to create an outcomes-based payment pathway for chronic-condition management, care coordination, and health-related social needs (“HRSN”) integration. The ACCESS Model claims to be different from other models. This is because it establishes a structure that allows a wide range of Medicare Part B-enrolled organizations—including physician practices, digital chronic-care platforms, home-based providers, and community-supported care organizations—to receive Medicare payments tied directly to clinical and equity-related…

December 2025

HCPCS Q1 2026

Sometimes when you work in reimbursement, you feel like a total loser. Today, I am feeling that way. As you all know, I do not distribute the new ASPs in this newsletter each quarter. My attorneys do not want me discussing drug margins EVER, and publishing pricing might infer that. A little paranoid--but it is what it is. Anyway, I went into the ASP files , now also known as the Payment Limit Files, and I was shocked (which many of you may not be) that some drugs are being paid at AMP, Average Manufacturers' Price. AMP is generally only used for Medicaid rebates. I suddenly remembered that CMS uses AMP when the Office of Inspector General (OIG aka the Oy General) informs CMS that a product’s ASP is at least 5% higher than its AMP; the ASP for the billing code has exceeded the AMP for the billing code by 5% or more in two consecutive quarters, or three of the previous four quarters immediately preceding the quarter to which the price substitution would be applied. I was just shocked…

December 2025

Get Ready! Get Set for 2026!

Well, the new year is almost upon us!!! To help you during this super-busy time of year, I have a little checklist for you to make sure you haven't forgotten anything before you start imbibing holiday cheer. And here it is: Verify all patient insurance for those in treatment. This year, it is particularly poignant, as many patients on the Exchange (Obamacare) may drop their plans or stop paying premiums in the next year. Also, Medicare patients may be going on or off Medicare Advantage. Get authorizations for each plan and/or patient where authorization must be renewed annually or (God forbid) quarterly. Pre-authorize all drugs, therapies (i.e., Radiation), and other services/procedures with new codes (e.g., RPM, RTM). Make sure insurance covers new codes and services in the new year, or when they are covered in 2026. Update your facility for the new codes you will use in 2026 in your EMR, Patient Accounting System, and pharmacy inventory. Update your charge entry for the new RVUs…